Jul 16th, 2024
GSK CEO and Fleming Initiative Chair on Fighting Drug-Resistant 'Superbugs'
Emma Walmsley, CEO of GSK and Ara Darzi, Executive Director of the Fleming Initiative and Imperial College's Director of the Institute of Global Health Innovation, on their efforts to combat the rise of antimicrobial resistance. They join Bloomberg's Francine Lacqua on 'The Pulse'.







